Foundation Medicine extends collaboration with Novartis

Foundation Medicine says it's expanding a collaboration with Novartis, under which the Cambridge biotech’s genomic profiling expertise will continue to be used by the Swiss drug giant to develop new cancer drugs...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.